These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12975714)

  • 1. A retrospective review of the effect of COX-2 inhibitors on blood pressure change.
    Cho J; Cooke CE; Proveaux W
    Am J Ther; 2003; 10(5):311-7. PubMed ID: 12975714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib.
    Nietert PJ; Ornstein SM; Dickerson LM; Rothenberg RJ
    Pharmacotherapy; 2003 Nov; 23(11):1416-23. PubMed ID: 14620388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure in Native Americans switched from celecoxib to rofecoxib.
    Fredy J; Diggins DA; Morrill GB
    Ann Pharmacother; 2005 May; 39(5):797-802. PubMed ID: 15797981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.
    Whelton A; Fort JG; Puma JA; Normandin D; Bello AE; Verburg KM;
    Am J Ther; 2001; 8(2):85-95. PubMed ID: 11304662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
    Whelton A; White WB; Bello AE; Puma JA; Fort JG;
    Am J Cardiol; 2002 Nov; 90(9):959-63. PubMed ID: 12398962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
    Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
    Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new COX-2 inhibitors. Celecoxib and rofecoxib.
    Takanishi GC
    Indian J Med Sci; 2000 Jul; 54(7):299-302. PubMed ID: 11143851
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?
    Aw TJ; Liew D; Tofler GH; Schneider HG; Morel-Kopp MC; Billah B; Krum H
    J Hypertens; 2006 Oct; 24(10):1979-84. PubMed ID: 16957557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.
    White WB; Kent J; Taylor A; Verburg KM; Lefkowith JB; Whelton A
    Hypertension; 2002 Apr; 39(4):929-34. PubMed ID: 11967252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of rofecoxib and celecoxib with warfarin.
    Schaefer MG; Plowman BK; Morreale AP; Egan M
    Am J Health Syst Pharm; 2003 Jul; 60(13):1319-23. PubMed ID: 12901032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
    Becker RV; Burke TA; McCoy MA; Trotter JP
    Clin Ther; 2003 Feb; 25(2):647-62. PubMed ID: 12749519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.
    Phelan KM; Mosholder AD; Lu S
    J Clin Psychiatry; 2003 Nov; 64(11):1328-34. PubMed ID: 14658947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Wolfe F; Zhao S; Pettitt D
    J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension.
    Osterhaus JT; Burke TA; May C; Wentworth C; Whelton A; Bristol S
    Clin Ther; 2002 Jun; 24(6):969-89. PubMed ID: 12117086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics.
    Izhar M; Alausa T; Folker A; Hung E; Bakris GL
    Hypertension; 2004 Mar; 43(3):573-7. PubMed ID: 14744921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclooxygenase-2 inhibitors on blood pressure.
    Johnson DL; Hisel TM; Phillips BB
    Ann Pharmacother; 2003 Mar; 37(3):442-6. PubMed ID: 12639178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
    Grover SA; Coupal L; Zowall H
    Hypertension; 2005 Jan; 45(1):92-7. PubMed ID: 15545508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.